These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 27550791)

  • 21. Cancer biomarker discovery and translation: proteomics and beyond.
    Hristova VA; Chan DW
    Expert Rev Proteomics; 2019 Feb; 16(2):93-103. PubMed ID: 30556752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of CE-MS-identified proteome-based biomarker panels in drug development and patient management.
    Stepczynska A; Schanstra JP; Mischak H
    Bioanalysis; 2016; 8(5):439-55. PubMed ID: 26891752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
    Findeisen P; Neumaier M
    Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of oncoproteomics to cancer biomarker discovery.
    Cho WC
    Mol Cancer; 2007 Apr; 6():25. PubMed ID: 17407558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mining the Human Proteome: Biomarker Discovery for Human Cancer and Metastases.
    Yang J; Roy R; Jedinak A; Moses MA
    Cancer J; 2015; 21(4):327-36. PubMed ID: 26222086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma Biomarker Identification and Quantification by Microparticle Proteomics.
    Harel M; Geiger T
    Methods Mol Biol; 2017; 1619():477-486. PubMed ID: 28674905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topic model-based mass spectrometric data analysis in cancer biomarker discovery studies.
    Wang M; Tsai TH; Di Poto C; Ferrarini A; Yu G; Ressom HW
    BMC Genomics; 2016 Aug; 17 Suppl 4(Suppl 4):545. PubMed ID: 27535232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteome profiling reveals gender differences in the composition of human serum.
    Miike K; Aoki M; Yamashita R; Takegawa Y; Saya H; Miike T; Yamamura K
    Proteomics; 2010 Jul; 10(14):2678-91. PubMed ID: 20480504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics.
    Hudler P; Kocevar N; Komel R
    ScientificWorldJournal; 2014; 2014():260348. PubMed ID: 24550697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative proteomic analysis of human malignant ascitic fluids for the development of gastric cancer biomarkers.
    Jin J; Son M; Kim H; Kim H; Kong SH; Kim HK; Kim Y; Han D
    Clin Biochem; 2018 Jun; 56():55-61. PubMed ID: 29654727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis.
    Guo X; Hao Y; Kamilijiang M; Hasimu A; Yuan J; Wu G; Reyimu H; Kadeer N; Abudula A
    Tumour Biol; 2015 Mar; 36(3):1711-20. PubMed ID: 25427637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum proteomics in biomedical research: a systematic review.
    Zhang AH; Sun H; Yan GL; Han Y; Wang XJ
    Appl Biochem Biotechnol; 2013 Jun; 170(4):774-86. PubMed ID: 23609910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomics-driven cancer biomarker discovery: looking to the future.
    Simpson RJ; Bernhard OK; Greening DW; Moritz RL
    Curr Opin Chem Biol; 2008 Feb; 12(1):72-7. PubMed ID: 18295612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct Assessment of Plasma/Serum Sample Quality for Proteomics Biomarker Investigation.
    Greco V; Piras C; Pieroni L; Urbani A
    Methods Mol Biol; 2017; 1619():3-21. PubMed ID: 28674873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomic Approaches for Biomarker Panels in Cancer.
    Tanase C; Albulescu R; Neagu M
    J Immunoassay Immunochem; 2016; 37(1):1-15. PubMed ID: 26565430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative plasma proteome analysis of lymphoma-bearing SJL mice.
    Bhat VB; Choi MH; Wishnok JS; Tannenbaum SR
    J Proteome Res; 2005; 4(5):1814-25. PubMed ID: 16212437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum proteome profiling of primary breast cancer indicates a specific biomarker profile.
    Böhm D; Keller K; Wehrwein N; Lebrecht A; Schmidt M; Kölbl H; Grus FH
    Oncol Rep; 2011 Nov; 26(5):1051-6. PubMed ID: 21837365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Revisiting biomarker discovery by plasma proteomics.
    Geyer PE; Holdt LM; Teupser D; Mann M
    Mol Syst Biol; 2017 Sep; 13(9):942. PubMed ID: 28951502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
    Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
    J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progress in the identification of plasma biomarkers of colorectal cancer.
    Coghlin C; Murray GI
    Proteomics; 2013 Aug; 13(15):2227-8. PubMed ID: 23818135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.